Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
HCAT Health Catalyst Inc
- Stocks
- Healthcare
- NASDAQ: HCAT
Price (delayed)
$4.13
Market cap
$289.97M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.15
Enterprise value
$442.59M
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage
Highlights
HCAT's EPS is up by 45% year-on-year and by 14% since the previous quarter
The net income has grown by 41% YoY and by 12% from the previous quarter
Health Catalyst's quick ratio has plunged by 68% YoY
The company's debt has surged by 62% YoY and by 10% QoQ
Key stats
What are the main financial stats of HCAT
Market
Valuations
Earnings
Shares outstanding
70.21M
Market cap
$289.97M
Enterprise value
$442.59M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.69
Price to sales (P/S)
0.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.44
Revenue
$306.58M
Gross profit
$140.78M
Operating income
-$69.81M
Net income
-$69.5M
EBIT
-$69.81M
EBITDA
-$25.69M
Free cash flow
-$1.32M
Per share
Balance sheet
Liquidity
EPS
-$1.15
EPS diluted
-$1.15
Free cash flow per share
-$0.02
Book value per share
$6
Revenue per share
$5.09
TBVPS
$8.53
Total assets
$858.93M
Total liabilities
$493.72M
Debt
$402.27M
Equity
$365.21M
Working capital
$139.8M
Debt to equity
1.1
Current ratio
1.43
Quick ratio
1.38
Net debt/EBITDA
-5.94
Margins
Efficiency
Dividend
EBITDA margin
-8.4%
Gross margin
45.9%
Net margin
-22.7%
Operating margin
-22.8%
Return on assets
-9.1%
Return on equity
-19.4%
Return on invested capital
-25.5%
Return on capital employed
-13.1%
Return on sales
-22.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCAT stock price
How has the Health Catalyst stock price performed over time
Intraday
-1.2%
1 week
-1.43%
1 month
2.74%
1 year
-38.08%
YTD
-41.58%
QTD
-8.83%
Financial performance
How have Health Catalyst's revenue and profit performed over time
Revenue
$306.58M
Gross profit
$140.78M
Operating income
-$69.81M
Net income
-$69.5M
Gross margin
45.9%
Net margin
-22.7%
The operating margin rose by 47% YoY and by 19% QoQ
The operating income is up by 45% year-on-year and by 18% since the previous quarter
The company's net margin rose by 43% YoY and by 13% QoQ
The net income has grown by 41% YoY and by 12% from the previous quarter
Price vs fundamentals
How does HCAT's price correlate with its fundamentals
Growth
What is Health Catalyst's growth rate over time
Valuation
What is Health Catalyst stock price valuation
P/E
N/A
P/B
0.69
P/S
0.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.44
HCAT's EPS is up by 45% year-on-year and by 14% since the previous quarter
HCAT's price to book (P/B) is 75% lower than its 5-year quarterly average of 2.8 and 42% lower than its last 4 quarters average of 1.2
The company's equity rose by 2.9% QoQ
The stock's price to sales (P/S) is 83% less than its 5-year quarterly average of 4.8 and 41% less than its last 4 quarters average of 1.4
The company's revenue rose by 3.6% YoY
Efficiency
How efficient is Health Catalyst business performance
HCAT's ROS is up by 47% year-on-year and by 14% since the previous quarter
Health Catalyst's return on assets has increased by 46% YoY and by 17% QoQ
HCAT's return on equity is up by 40% year-on-year and by 12% since the previous quarter
Dividends
What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCAT.
Financial health
How did Health Catalyst financials performed over time
HCAT's total assets is 74% greater than its total liabilities
Health Catalyst's quick ratio has plunged by 68% YoY
The current ratio has plunged by 68% YoY
The company's debt is 10% higher than its equity
The company's debt has surged by 62% YoY and by 10% QoQ
The debt to equity has soared by 62% year-on-year and by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.